Chiome Bioscience Inc.

4583

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-13FY2026 Q2

Revenue

6.2100M JPY

YoY -20.0%

Operating Income

-4.8100M JPY

YoY +10.6%

Net Income

-9.3100M JPY

YoY +7.2%

EPS

-6.6JPY

YoY +16.9%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

7.8億円

2.2億円

-3.5億円

-9.1億円

-14.8億円

Rev: 7.1億円Op: -13.3億円NI: -14.8億円

Rev: 6.3億円Op: -12.6億円NI: -12.4億円

Rev: 6.8億円Op: -12.1億円NI: -12.2億円

Rev: 7.8億円Op: -10.3億円NI: -10.2億円

Rev: 5.9億円Op: -9.8億円NI: -9.8億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income-

Revenue Progress2.700M

Revenue Forecast-

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan